Joachim Burman

Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis

Kosek, Sonja; Wiberg, Anna; Persson, Barbro; Gabrysch, Katja et al.

Part of Journal of Neuroimmunology, 2026

• DOI for Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis
• Download full text (pdf) of Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis

The MMP-9/TIMP-1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Pavlovic, Ivan; Erngren, Ida; Kultima, Kim; Larsson, Anders et al.

Part of Annals of Clinical and Translational Neurology, p. 442-452, 2026

• DOI for The MMP-9/TIMP-1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation
• Download full text (pdf) of The MMP-9/TIMP-1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis

Vaivade, Aina; Parakkal Sreenivasan, Akshai; Erngren, Ida; Freyhult, Eva et al.

Part of Environment International, 2026

• DOI for Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis
• Download full text (pdf) of Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis

Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis

Katsarogiannis, Evangelos; Ouellette, Russell; Virhammar, Johan; Landtblom, Anne-Marie et al.

Part of Journal of Neuroimaging, 2026

• DOI for Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis
• Download full text (pdf) of Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Greco, Raffaella; Saccardi, Riccardo; Ponzano, Marta; Badoglio, Manuela et al.

Part of Bone Marrow Transplantation, p. 1628-1634, 2025

• DOI for BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
• Download full text (pdf) of BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis

Kosek, Sonja; Wiberg, Anna; Persson, Barbro; Gabrysch, Katja et al.

Part of Journal of Neuroimmunology, 2026

• DOI for Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis
• Download full text (pdf) of Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis

The MMP-9/TIMP-1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Pavlovic, Ivan; Erngren, Ida; Kultima, Kim; Larsson, Anders et al.

Part of Annals of Clinical and Translational Neurology, p. 442-452, 2026

• DOI for The MMP-9/TIMP-1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation
• Download full text (pdf) of The MMP-9/TIMP-1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis

Vaivade, Aina; Parakkal Sreenivasan, Akshai; Erngren, Ida; Freyhult, Eva et al.

Part of Environment International, 2026

• DOI for Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis
• Download full text (pdf) of Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis

Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis

Katsarogiannis, Evangelos; Ouellette, Russell; Virhammar, Johan; Landtblom, Anne-Marie et al.

Part of Journal of Neuroimaging, 2026

• DOI for Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis
• Download full text (pdf) of Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Greco, Raffaella; Saccardi, Riccardo; Ponzano, Marta; Badoglio, Manuela et al.

Part of Bone Marrow Transplantation, p. 1628-1634, 2025

• DOI for BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
• Download full text (pdf) of BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis

Sreenivasan, Akshai Parakkal; Vaivade, Aina; Noui, Yassine; Emami Khoonsari, Payam et al.

Part of npj Digital Medicine, 2025

• DOI for Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis
• Download full text (pdf) of Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis

Predictors of Ability to Work in Multiple Sclerosis

Wellhagen, Gustaf; Ueckert, Sebastian; Nielsen, Elisabet I.; Smith, Carl et al.

Part of CPT, p. 2244-2251, 2025

• DOI for Predictors of Ability to Work in Multiple Sclerosis
• Download full text (pdf) of Predictors of Ability to Work in Multiple Sclerosis

Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Vaivade, Aina; Erngren, Ida; Carlsson, Henrik; Freyhult, Eva et al.

Part of Nature Communications, 2025

• DOI for Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening
• Download full text (pdf) of Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening

Erngren, Ida; Vaivade, Aina; Carlsson, Henrik; Al-Grety, Asma et al.

Part of BMC Medicine, 2025

• DOI for Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening
• Download full text (pdf) of Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening

Plasma profiles of neuroglial injury biomarkers after ischemic stroke

Sjölin, Karl; Röyter, Björn; Forgo, Bianka; Aulin, Julia et al.

Part of Translational Stroke Research, p. 2185-2194, 2025

• DOI for Plasma profiles of neuroglial injury biomarkers after ischemic stroke
• Download full text (pdf) of Plasma profiles of neuroglial injury biomarkers after ischemic stroke

Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Kosek, Sonja; Kilsved, Ellen; Danfors, Torsten; Cunningham, Janet L et al.

Part of Clinical Nuclear Medicine, p. 208-213, 2025

• DOI for Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Response to: "Circular reasoning concerning red flags for predicting rituximab response in OCD"

Gallwitz, Maike; Lindqvist, Isa; Rasmusson, Annica J.; Cervenka, Simon et al.

Part of Molecular Psychiatry, p. 3323-3324, 2025

• DOI for Response to: "Circular reasoning concerning red flags for predicting rituximab response in OCD"
• Download full text (pdf) of Response to: "Circular reasoning concerning red flags for predicting rituximab response in OCD"

Micro-RNA Signature in CSF Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Pavlovic, Ivan; Axling, Fredrik; Hayat Nazir, Faisal; Müller, Malin et al.

Part of Neurology, 2025

• DOI for Micro-RNA Signature in CSF Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
• Download full text (pdf) of Micro-RNA Signature in CSF Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation.

Erngren, Ida; Lundblad, Katarina; Pavlovic, Ivan; Al-Grety, Asma et al.

Part of Journal of Neuroinflammation, 2025

• DOI for Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation.
• Download full text (pdf) of Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation.

Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis

Noui, Yassine; Zjukovskaja, Christina; Silfverberg, Thomas; Ljungman, Per et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 966-974, 2025

• DOI for Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis

Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic Stroke

Sjölin, Karl; Röyter, Björn; Forgo, Bianka; Aulin, Julia et al.

Part of Translational Stroke Research, 2025

• DOI for Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic Stroke

Longitudinal immune profiling following autologous hematopoietic stem cell transplantation in multiple sclerosis: insights into immune reconstitution and disease modulation

Müller, Malin; Pavlovic, Ivan; Wiberg, Anna; Burman, Joachim

Part of Frontiers in Immunology, 2025

• DOI for Longitudinal immune profiling following autologous hematopoietic stem cell transplantation in multiple sclerosis: insights into immune reconstitution and disease modulation
• Download full text (pdf) of Longitudinal immune profiling following autologous hematopoietic stem cell transplantation in multiple sclerosis: insights into immune reconstitution and disease modulation

Impact of image reconstruction on cerebral blood flow measured with ¹⁵O-water positron emission tomography

Bäck, Elin; Jonasson, My; Lindström, Elin; Tolf, Andreas et al.

Part of EJNMMI Physics, 2025

• DOI for Impact of image reconstruction on cerebral blood flow measured with ¹⁵O-water positron emission tomography
• Download full text (pdf) of Impact of image reconstruction on cerebral blood flow measured with ¹⁵O-water positron emission tomography

Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment

Gallwitz, Maike; Lindqvist, Isa; Mulder, Jan; Rasmusson, Annica J. et al.

Part of Molecular Psychiatry, p. 1396-1406, 2025

• DOI for Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment
• Download full text (pdf) of Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment

Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis

Mitrache Desaga, Ann-Christine; Noui, Yassine; Silfverberg, Thomas; Carlson, Kristina et al.

Part of Multiple Sclerosis Journal, p. 455-463, 2025

• DOI for Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis

Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation

Aulin, Julia; Sjölin, Karl; Lindbäck, Johan; Benz, Alexander P. et al.

Part of Journal of the American Heart Association, 2025

• DOI for Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
• Download full text (pdf) of Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation

Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series

Kosek, Sonja; Burman, Joachim; Rostedt Punga, Anna

Part of Brain and Behavior, 2024

• DOI for Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
• Download full text (pdf) of Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series

Evoked potentials after autologous hematopoietic stem cell transplantation for multiple sclerosis

Katsarogiannis, Evangelos; Axelson, Hans; Berntsson, Shala; Rothkegel, Holger et al.

Part of Multiple Sclerosis and Related Disorders, 2024

• DOI for Evoked potentials after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Evoked potentials after autologous hematopoietic stem cell transplantation for multiple sclerosis

Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation

Pavlovic, Ivan; Zjukovskaja, Christina; Hayat Nazir, Faisal; Müller, Malin et al.

Part of Multiple Sclerosis and Related Disorders, 2024

• DOI for Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation
• Download full text (pdf) of Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Silfverberg, Thomas; Zjukovskaja, Christina; Noui, Yassine; Carlson, Kristina et al.

Part of Bone Marrow Transplantation, p. 1601-1610, 2024

• DOI for BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis
• Download full text (pdf) of BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 125-133, 2024

• DOI for Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Download full text (pdf) of Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation

Aulin, Julia; Sjölin, Karl; Lindbäck, Johan; Benz, Alexander P et al.

Part of Circulation, p. 1090-1100, 2024

• DOI for Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation

Hematopoietic stem cell transplantation for neuromyelitis optica spectrum disorder: Can immune tolerance be reestablished?

Burt, Richard K; Burman, Joachim; Greco, Raffaella; Rose, John W

Part of Handbook of Clinical Neurology, p. 169-197, 2024

• DOI for Hematopoietic stem cell transplantation for neuromyelitis optica spectrum disorder: Can immune tolerance be reestablished?

Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP?

Burt, Richard K; Burman, Joachim; Barker, Alexander; Sharrack, Basil

Part of Handbook of Clinical Neurology, p. 199-238, 2024

• DOI for Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP?

COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab

Piehl, Fredrik; Alping, Peter; Virtanen, Suvi; Englund, Simon et al.

Part of Annals of Neurology, p. 678-693, 2024

• DOI for COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
• Download full text (pdf) of COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab

An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Syk, Mikaela; Tornvind, Emma; Gallwitz, Maike; Fällmar, David et al.

Part of Translational Psychiatry, 2024

• DOI for An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
• Download full text (pdf) of An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis

Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne; Massey, Jennifer et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 775-783, 2024

• DOI for Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis

Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study

Tolf, Andreas; Gauffin, Helena; Burman, Joachim; Landtblom, Anne-Marie et al.

Part of PLOS ONE, 2024

• DOI for Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study
• Download full text (pdf) of Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study

Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population

Tigchelaar, Celien; Cunningham, Janet L.; Rasmusson, Annica J.; Thulin, Måns et al.

Part of iScience, 2024

• DOI for Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population
• Download full text (pdf) of Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Longinetti, Elisa; Englund, Simon; Burman, Joachim; Fink, Katharina et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 134-141, 2024

• DOI for Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
• Download full text (pdf) of Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

Greco, Raffaella; Alexander, Tobias; Del Papa, Nicoletta; Mueller, Fabian et al.

Part of eClinicalMedicine, 2024

• DOI for Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
• Download full text (pdf) of Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis

Burman, Joachim; Zhukovskaja, Christina; Svenningsson, Anders; Freyhult, Eva et al.

Part of Brain Communications, 2023

• DOI for Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
• Download full text (pdf) of Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis

CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Lundblad, Katarina; Zjukovskaja, Christina; Larsson, Anders; Cherif, Honar et al.

Part of Neurology, 2023

• DOI for CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
• Download full text (pdf) of CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Experiences in implementing immunopsychiatry in real life

Cunningham, Janet L.; Nordmark, Gunnel; Fällmar, David; Cervenka, Simon et al.

Part of Journal of Affective Disorders Reports, 2023

• DOI for Experiences in implementing immunopsychiatry in real life
• Download full text (pdf) of Experiences in implementing immunopsychiatry in real life

Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden

Kosek, Sonja; Persson, Barbro; Rodrigues, Rui; Malmestrom, Clas et al.

Part of Acta Neurologica Scandinavica, 2023

• DOI for Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden
• Download full text (pdf) of Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden

Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines

Nazir, Faisal Hayat; Wiberg, Anna; Müller, Malin; Mangsbo, Sara et al.

Part of Brain Communications, 2023

• DOI for Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines
• Download full text (pdf) of Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines

Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zafeiri, Lida; Åkerfeldt, Torbjörn; Tolf, Andreas; Carlson, Kristina et al.

Part of PLOS ONE, 2023

• DOI for Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation

Sjölin, Karl; Christersson, Christina; James, Stefan; Lindbäck, Johan et al.

Part of Cardiology, p. 478-483, 2023

• DOI for Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation
• Download full text (pdf) of Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation

Disease phenotype prediction in multiple sclerosis

Herman, Stephanie; Arvidsson McShane, Staffan; Zhukovsky, Christina; Emami, Payam et al.

Part of iScience, 2023

• DOI for Disease phenotype prediction in multiple sclerosis
• Download full text (pdf) of Disease phenotype prediction in multiple sclerosis

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Braun, Madelen; Boström, Gustaf; Ingelsson, Martin; Kilander, Lena et al.

Part of Fluids and Barriers of the CNS, 2023

• DOI for Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
• Download full text (pdf) of Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort

Englund, Simon; Kierkegaard, Marie; Burman, Joachim; Fink, Katharina et al.

Part of Multiple Sclerosis and Related Disorders, 2023

• DOI for Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne; Freedman, Mark S. et al.

Part of JAMA Neurology, p. 702-713, 2023

• DOI for Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Vaivade, Aina; Wiberg, Anna; Khoonsari, Payam Emami; Carlsson, Henrik et al.

Part of Lipids in Health and Disease, 2023

• DOI for Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
• Download full text (pdf) of Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction

Young, Peter; Appel, Lieuwe; Tolf, Andreas; Kosmidis, Savvas et al.

Part of EJNMMI Physics, 2023

• DOI for Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction
• Download full text (pdf) of Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction

COVID-19 clinical outcomes and DMT of MS patients and population-based controls

Longinetti, Elisa; Bower, Hannah; McKay, Kyla A.; Englund, Simon et al.

Part of Annals of Clinical and Translational Neurology, p. 1449-1458, 2022

• DOI for COVID-19 clinical outcomes and DMT of MS patients and population-based controls
• Download full text (pdf) of COVID-19 clinical outcomes and DMT of MS patients and population-based controls

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Sjölin, Karl; Aulin, Julia; Wallentin, Lars; Eriksson, Niclas et al.

Part of Journal of the American Heart Association, 2022

• DOI for Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
• Download full text (pdf) of Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Temporal trends of epilepsy in multiple sclerosis

Mahamud, Zamzam; Burman, Joachim; Zelano, Johan

Part of Acta Neurologica Scandinavica, p. 492-498, 2022

• DOI for Temporal trends of epilepsy in multiple sclerosis
• Download full text (pdf) of Temporal trends of epilepsy in multiple sclerosis

Distribution of five clinically important neuroglial proteins in the human brain.

Sjölin, Karl; Kultima, Kim; larsson, Anders; Freyhult, Eva et al.

Part of Molecular brain, 2022

• DOI for Distribution of five clinically important neuroglial proteins in the human brain.
• Download full text (pdf) of Distribution of five clinically important neuroglial proteins in the human brain.

Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT

Kvistad, Silje Agnethe Stokke; Burman, Joachim; Lehmann, Anne Kristine; Tolf, Andreas et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 844-848, 2022

• DOI for Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT
• Download full text (pdf) of Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT

Evaluation of polarity switching for untargeted lipidomics using liquid chromatography coupled to high resolution mass spectrometry

Carlsson, Henrik; Vaivade, Aina; Emami Khoonsari, Payam; Burman, Joachim et al.

Part of Journal of chromatography. B, 2022

• DOI for Evaluation of polarity switching for untargeted lipidomics using liquid chromatography coupled to high resolution mass spectrometry
• Download full text (pdf) of Evaluation of polarity switching for untargeted lipidomics using liquid chromatography coupled to high resolution mass spectrometry

Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

Tolf, Andreas; Wiberg, Anna; Müller, Malin; Nazir, Faisal Hayat et al.

Part of JAMA Network Open, 2022

• DOI for Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
• Download full text (pdf) of Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology

Lauren, Ida; Havervall, Sebastian; Ng, Henry; Lord, Martin et al.

Part of Immunity, Inflammation and Disease, 2022

• DOI for Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
• Download full text (pdf) of Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology

Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zhukovsky, Christina; Larsson, Anders; Cherif, Honar; Kultima, Kim et al.

Part of Multiple Sclerosis and Related Disorders, 2022

• DOI for Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis

Tedeholm, H.; Piehl, F.; Lycke, J.; Link, J. et al.

Part of Multiple Sclerosis and Related Disorders, 2022

• DOI for Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
• Download full text (pdf) of Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Svenningsson, Anders; Frisell, Thomas; Burman, Joachim; Salzer, Jonatan et al.

Part of Lancet Neurology, p. 693-703, 2022

• DOI for Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

Alexander, Tobias; Snowden, John A.; Burman, Joachim; Chang, Hyun-Dong et al.

Part of Frontiers in Oncology, 2021

• DOI for Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT
• Download full text (pdf) of Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing

Carlsson, Henrik; Rollborn, Niclas; Herman, Stephanie; Freyhult, Eva et al.

Part of Metabolites, 2021

• DOI for Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
• Download full text (pdf) of Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing

Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid

Peters, Kristian; Herman, Stephanie; Emami Khoonsari, Payam; Burman, Joachim et al.

Part of Scientific Reports, 2021

• DOI for Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid
• Download full text (pdf) of Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Niemelä, Valter; Landtblom, Anne-Marie; Nyholm, Dag; Kneider, Maria et al.

Part of Movement Disorders, p. 481-491, 2021

• DOI for Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
• Download full text (pdf) of Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension

Bergman, Joakim; Burman, Joachim; Bergenheim, Tommy; Svenningsson, Anders

Part of Journal of Neurology, p. 651-657, 2021

• DOI for Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension
• Download full text (pdf) of Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension

Cerebral blood flow measurements with ¹⁵O-water PET using a non-invasive machine-learning-derived arterial input function

Kuttner, Samuel; Wickstrøm, Kristoffer Knutsen; Lubberink, Mark; Tolf, Andreas et al.

Part of Journal of Cerebral Blood Flow and Metabolism, p. 2229-2241, 2021

• DOI for Cerebral blood flow measurements with ¹⁵O-water PET using a non-invasive machine-learning-derived arterial input function
• Download full text (pdf) of Cerebral blood flow measurements with ¹⁵O-water PET using a non-invasive machine-learning-derived arterial input function

Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study

Mahamud, Zamzam; Hakansson, Samuel; Burman, Joachim; Zelano, Johan

Part of Epilepsy & Behavior, 2021

• DOI for Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study
• Download full text (pdf) of Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study

Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-β treatment

Zhukovsky, Christina; Herman, Stephanie; Wiberg, Anna; Cunningham, Janet et al.

Part of Acta Neurologica Scandinavica, p. 602-607, 2021

• DOI for Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-β treatment
• Download full text (pdf) of Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-β treatment

Delaying the inevitable: Are disease modifying drugs for progressive MS worthwhile?

Burman, Joachim

Part of Multiple Sclerosis and Related Disorders, 2021

• DOI for Delaying the inevitable: Are disease modifying drugs for progressive MS worthwhile?

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 189-194, 2021

• DOI for Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
• Download full text (pdf) of Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

Alping, Peter; Burman, Joachim; Lycke, Jan; Frisell, Thomas et al.

Part of Neurology, 2021

• DOI for Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis
• Download full text (pdf) of Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Greco, Raffaella; Alexander, Tobias; Burman, Joachim; Del Papa, Nicoletta et al.

Part of Bone Marrow Transplantation, p. 1493-1508, 2021

• DOI for Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
• Download full text (pdf) of Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis

Das, J.; Snowden, J. A.; Burman, Joachim; Freedman, M. S. et al.

Part of Multiple Sclerosis Journal, p. 1198-1204, 2021

• DOI for Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis
• Download full text (pdf) of Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis

Multipel skleros och covid-19 – kunskapen ännu begränsad

Iacobaeus, Ellen; Burman, Joachim; Landtblom, Anne-Marie

Part of Läkartidningen, 2020

Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

Bergman, Joakim; Svenningsson, Anders; Liv, Per; Bergenheim, Tommy et al.

Part of Fluids and Barriers of the CNS, 2020

• DOI for Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS
• Download full text (pdf) of Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Larsson, Diane; Åkerfeldt, Torbjörn; Carlson, Kristina; Burman, Joachim

Part of Multiple Sclerosis Journal, p. 1351-1359, 2020

• DOI for Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS

Granqvist, Mathias; Burman, Joachim; Gunnarsson, Martin; Lycke, Jan et al.

Part of Multiple Sclerosis Journal, p. 1532-1539, 2020

• DOI for Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

Sharrack, Basil; Saccardi, Riccardo; Alexander, Tobias; Badoglio, Manuela et al.

Part of Bone Marrow Transplantation, p. 283-306, 2020

• DOI for Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
• Download full text (pdf) of Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

Tappenden, P.; Wang, Y.; Sharrack, B.; Burman, Joachim et al.

Part of Bone Marrow Transplantation, p. 1473-1475, 2020

• DOI for Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Alping, Peter; Askling, Johan; Burman, Joachim; Fink, Katharina et al.

Part of Annals of Neurology, p. 688-699, 2020

• DOI for Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
• Download full text (pdf) of Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Prognostic impact of epilepsy in multiple sclerosis

Mahamud, Zamzam; Burman, Joachim; Zelano, Johan

Part of Multiple Sclerosis and Related Disorders, 2020

• DOI for Prognostic impact of epilepsy in multiple sclerosis

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Luna, Gustavo; Alping, Peter; Burman, Joachim; Fink, Katharina et al.

Part of JAMA Neurology, p. 184-191, 2020

• DOI for Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry

Carlsson, Henrik; Abujrais, Sandy; Herman, Stephanie; Emami Khoonsari, Payam et al.

Part of Metabolomics, 2020

• DOI for Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
• Download full text (pdf) of Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry

Profound but Transient Changes in the Inflammatory Milieu of the Blood During Autologous Hematopoietic Stem Cell Transplantation

Wiberg, Anna; Strömberg, Ulla Ohlsson; Herman, Stephanie; Kultima, Kim et al.

Part of Biology of blood and marrow transplantation, p. 50-57, 2020

• DOI for Profound but Transient Changes in the Inflammatory Milieu of the Blood During Autologous Hematopoietic Stem Cell Transplantation

Container-based bioinformatics with Pachyderm

Novella, Jon Ander; Emami Khoonsari, Payam; Herman, Stephanie; Whitenack, Daniel et al.

Part of Bioinformatics, p. 839-846, 2019

• DOI for Container-based bioinformatics with Pachyderm

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Tolf, Andreas; Fagius, Jan; Carlson, Kristina; Åkerfeldt, Torbjörn et al.

Part of Acta Neurologica Scandinavica, p. 320-327, 2019

• DOI for Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects

Herman, Stephanie; Niemelä, Valter; Emami Khoonsari, Payam; Sundblom, Jimmy et al.

Part of Scientific Reports, 2019

• DOI for Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects
• Download full text (pdf) of Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects

Interoperable and scalable data analysis with microservices: Applications in metabolomics

Emami Khoonsari, Payam; Moreno, Pablo; Bergmann, Sven; Burman, Joachim et al.

Part of Bioinformatics, p. 3752-3760, 2019

• DOI for Interoperable and scalable data analysis with microservices: Applications in metabolomics
• Download full text (pdf) of Interoperable and scalable data analysis with microservices: Applications in metabolomics

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis

Herman, Stephanie; Åkerfeldt, Torbjörn; Spjuth, Ola; Burman, Joachim et al.

Part of Cells, 2019

• DOI for Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
• Download full text (pdf) of Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis

Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease

Feresiadou, Amalia; Nilsson, Kenneth; Ingelsson, Martin; Press, Rayomand et al.

Part of Journal of Neuroimmunology, p. 31-36, 2019

• DOI for Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease

Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations

Alping, Peter; Piehl, Fredrik; Langer-Gould, Annette; Frisell, Thomas et al.

Part of Epidemiology, p. 230-233, 2019

• DOI for Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations
• Download full text (pdf) of Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Burt, Richard K.; Balabanov, Roumen; Burman, Joachim; Sharrack, Basil et al.

Part of Journal of the American Medical Association (JAMA), p. 165-174, 2019

• DOI for Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.

Herman, Stephanie; Emami Khoonsari, Payam; Tolf, Andreas; Steinmetz, Julia et al.

Part of Theranostics, p. 4477-4490, 2018

• DOI for Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.
• Download full text (pdf) of Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)

Demirbuker, S. Safer; Kagström, S.; Fält, A.; Berglund, A. et al.

Part of Multiple Sclerosis Journal, p. 701-702, 2018

The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis.

Das, J.; Snowden, J.; Burman, Joachim; Freedman, M. et al.

Part of Multiple Sclerosis Journal, p. 87-88, 2018

Real-world longitudinal data of peginterferon beta-1a from a Swedish national post-marketing surveillance study (IMSE 6) - efficacy and safety profile

Kågström, S.; Fält, A.; Demirbuker, S. Safer; Berglund, A. et al.

Part of Multiple Sclerosis Journal, p. 927-928, 2018

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)

Fält, A.; Kagstrom, S.; Demirbuker, S. Safer; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 696-697, 2018

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)

Fält, A.; Kågström, S.; Demirbuker, S. Safer; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 706-707, 2018

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

Kagström, S.; Fält, A.; Demirbuker, S. Safer; Berglund, A. et al.

Part of Multiple Sclerosis Journal, p. 699-700, 2018

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4)

Demirbuker, S. Safer; Kågström, S.; Fält, A.; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 922-923, 2018

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease

Niemelä, Valter; Burman, Joachim; Blennow, Kaj; Zetterberg, Henrik et al.

Part of PLOS ONE, 2018

• DOI for Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease
• Download full text (pdf) of Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease

Non-myeloablative hematopoietic stem cell transplantation (HSCT) is superior to disease modifying drug (DMD) treatment in highly active Relapsing Remitting Multiple Sclerosis (RRMS): interim results of the Multiple Sclerosis International Stem cell Transplant (MIST) Randomized Trial

Burt, Richard K.; Balabanov, Roumen; Snowden, John A.; Sharrack, Basil et al.

Part of Neurology, 2018

Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study

Bergman, Joakim; Burman, Joachim; Gilthorpe, Jonathan D.; Zetterberg, Henrik et al.

Part of Neurology, 2018

• DOI for Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden: Outlier or predecessor?

Berntsson, Shala G.; Kristoffersson, A; Boström, I; Feresiadou, Amalia et al.

Part of Acta Neurologica Scandinavica, p. 327-331, 2018

• DOI for Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden: Outlier or predecessor?

Treatment of epilepsy in multiple sclerosis

Dagiasi, Loanna; Vall, Victor; Kumlien, Eva; Burman, Joachim et al.

Part of Seizure, p. 47-51, 2018

• DOI for Treatment of epilepsy in multiple sclerosis

Risk of epilepsy after a single seizure in multiple sclerosis

Mahamud, Z.; Burman, Joachim; Zelano, J.

Part of European Journal of Neurology, p. 854-860, 2018

• DOI for Risk of epilepsy after a single seizure in multiple sclerosis

Blogs cannot separate wheat from chaff

Burt, Richard K.; Snowden, John A.; Burman, Joachim; Oliveira, Maria Carolina et al.

Part of Science, p. 602-602, 2017

• DOI for Blogs cannot separate wheat from chaff

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of natalizumab (IMSE 1)

Kagstrom, S.; Leandersson, A.; Forsberg, L.; Berglund, A. et al.

Part of Multiple Sclerosis Journal, p. 365-366, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)

Leandersson, A.; Kagstrom, S.; Forsberg, L.; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 374-375, 2017

Corpus callosum atrophy in MS is halted by autologous haematopoietic stem cell transplantation

Tolf, Andreas; Granberg, T.; Larsson, Elna-Marie; Landtblom, Anne-Marie et al.

Part of Multiple Sclerosis Journal, p. 1006-1007, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)

Leandersson, A.; Kagstrom, S.; Forsberg, L.; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 888-889, 2017

The diagnosis of OCB-negative MS-patients - an inventory of the Swedish MS register in Uppsala, Sweden

Landtblom, Anne-Marie; Kristoffersson, A.; Jansson, L.; Burman, Joachim et al.

Part of Multiple Sclerosis Journal, p. 439-439, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)

Forsberg, L.; Kagstrom, S.; Leandersson, A.; Berglund, A. et al.

Part of Multiple Sclerosis Journal, p. 884-885, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4)

Forsberg, L.; Leandersson, A.; Kagstrom, S.; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 635-636, 2017

Baseline characteristics from the COMBAT-MS study: Initial analyses suggest main driver for therapy choice is geographic location

Alping, P.; Burman, Joachim; Fink, K.; Gunnarsson, M. et al.

Part of Multiple Sclerosis Journal, p. 714-714, 2017

Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment

Pauzuolis, Mindaugas; Eich, Torsten; Burman, Joachim

Part of PLOS ONE, 2017

• DOI for Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment
• Download full text (pdf) of Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

Snowden, John A.; Badoglio, Manuela; Labopin, Myriam; Giebel, Sebastian et al.

Part of Blood Advances, p. 2742-2755, 2017

• DOI for Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Burman, Joachim; Kirgizov, K; Carlson, Kristina; Badoglio, M et al.

Part of Bone Marrow Transplantation, p. 1133-1137, 2017

• DOI for Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients: First line drugs vs natalizumab

Fagius, Jan; Feresiadou, Amalia; Larsson, Elna-Marie; Burman, Joachim

Part of Multiple Sclerosis and Related Disorders, p. 82-87, 2017

• DOI for Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients: First line drugs vs natalizumab

Inflammatory immune response after autologous transplantation in neurologic diseases

Innocenti, C.; Burman, Joachim; Burns, C.; Burt, R.

Part of Bone Marrow Transplantation, 2017

• DOI for Inflammatory immune response after autologous transplantation in neurologic diseases

Epilepsy in multiple sclerosis: A nationwide population-based register study.

Burman, Joachim; Zelano, Johan

Part of Neurology, p. 2462-2468, 2017

• DOI for Epilepsy in multiple sclerosis: A nationwide population-based register study.

Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought

Burman, Joachim; Fox, Robert J.

Part of Neurology, p. 2072-2073, 2017

• DOI for Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)

Forsberg, L.; Johansson, S.; Hillert, J.; Nilsson, P. et al.

Part of Multiple Sclerosis Journal, p. 338-339, 2016

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

Johansson, S.; Forsberg, L.; Hillert, J.; Nilsson, P. et al.

Part of Multiple Sclerosis Journal, p. 336-337, 2016

Rituximab in multiple sclerosis; data from the swedish MS registry.

Alping, P.; Svenningsson, A.; Salzer, J.; Burman, Joachim et al.

Part of Multiple Sclerosis Journal, p. 49-49, 2016

Adverse events of rituximab in a Swedish MS population sample.

Bostrom, I.; Burman, Joachim; Landtblom, A-M

Part of Multiple Sclerosis Journal, p. 871-871, 2016

Real world experience of fingolimod after switching multiple sclerosis (MS) therapy; focus on natalizumab naive and experienced persons with MS, respectively

Forsberg, L.; Johansson, S.; Frisell, T.; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 647-648, 2016

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

Burman, Joachim; Raininko, Raili; Blennow, Kaj; Zetterberg, Henrik et al.

Part of Journal of Neuroimmunology, p. 52-57, 2016

• DOI for YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

Burman, Joachim; Svenningsson, Anders

Part of Journal of Neuroimmunology, p. 40-44, 2016

• DOI for Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of dimethyl fumarate

Forsberg, L.; Johansson, S.; Nordin, N.; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 286-287, 2015

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab

Johansson, S.; Forsberg, L.; Hillert, J.; Nilsson, P. et al.

Part of Multiple Sclerosis Journal, p. 285-286, 2015

The IMSE 2 study: a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of fingolimod

Johansson, S.; Forsberg, L.; Nordin, N.; Hillert, J. et al.

Part of Multiple Sclerosis Journal, p. 284-285, 2015

Severe relapses and rebound activity after natalizumab discontinuation in MS patients with more than five years of treatment with stable disease course

Fagius, Jan; Burman, Joachim; Feresiadou, Amalia; Larsson, Elna-Marie

Part of Multiple Sclerosis Journal, p. 297-297, 2015

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

Greco, Raffaella; Bondanza, Attilio; Oliveira, Maria Carolina; Badoglio, Manuela et al.

Part of Multiple Sclerosis Journal, p. 189-197, 2015

• DOI for Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

Rystedt, Alma; Zetterberg, Lena; Burman, Joachim; Nyholm, Dag et al.

Part of Clinical neuropharmacology, p. 170-176, 2015

• DOI for A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)

Snarski, E; Snowden, J A; Oliveira, M C; Simoes, B et al.

Part of Bone Marrow Transplantation, p. 216-220, 2015

• DOI for Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)

Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis

Burt, Richard K; Balabanov, Roumen; Han, Xiaoqiang; Sharrack, Basil et al.

Part of Journal of the American Medical Association (JAMA), p. 275-284, 2015

• DOI for Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis

A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of natalizumab

Jonsson, L.; Holmen, C.; Hillert, J.; Nilsson, P. et al.

Part of Multiple Sclerosis Journal, p. 166-166, 2014

Intranasal Delivery of CNS-Retargeted Human Mesenchymal Stromal Cells Prolongs Treatment Efficacy of Experimental Autoimmune Encephalomyelitis

Fransson, Moa; Piras, Elena; Wang, Hao; Burman, Joachim et al.

Part of Immunology, p. 431-441, 2014

• DOI for Intranasal Delivery of CNS-Retargeted Human Mesenchymal Stromal Cells Prolongs Treatment Efficacy of Experimental Autoimmune Encephalomyelitis

Assessing tissue damage in multiple sclerosis: a biomarker approach

Burman, Joachim; Zetterberg, H; Fransson, Moa; Loskog, Angelica SI. et al.

Part of Acta Neurologica Scandinavica, p. 81-89, 2014

• DOI for Assessing tissue damage in multiple sclerosis: a biomarker approach

Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis

Burman, Joachim; Svensson, Emma; Fransson, Moa; Loskog, Angelica et al.

Part of Journal of Neuroimmunology, p. 141-141, 2014

• DOI for Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis

Normal outcome of pregnancy with ongoing treatment with natalizumab

Fagius, Jan; Burman, Joachim

Part of Acta Neurologica Scandinavica, 2014

• DOI for Normal outcome of pregnancy with ongoing treatment with natalizumab

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Burman, Joachim; Iacobaeus, Ellen; Svenningsson, Anders; Lycke, Jan et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 1116-1121, 2014

• DOI for Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

Burman, Joachim; Svensson, Emma; Fransson, Moa; Loskog, Angelica S I et al.

Part of Journal of Neuroimmunology, p. 153-159, 2014

• DOI for The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

Burman, Joachim; Fransson, Moa; Tötterman, Thomas H.; Fagius, Jan et al.

Part of Immunology, p. 211-219, 2013

• DOI for T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Fransson, Moa; Piras, Elena; Burman, Joachim; Nilsson, Berith et al.

Part of Journal of Neuroinflammation, p. 112, 2012

• DOI for CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
• Download full text (pdf) of CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Svenska neurologföreningen: Antalet neurologer som behöver fördubblas under den kommande tioårsperioden

Remahl, Ingela Nilsson; Fredrikson, Sten; Gunnarsson, Martin; Hietala, Albert et al.

Part of Läkartidningen, p. 970-970, 2012

Autologous hematopoietic stem cell transplantation for multiple sclerosis: if confused or hesitant, remember 'Treat with standard immune suppressive drugs and if no inflammation, no response'

Burt, Richard K; Balabanov, Roumen; Voltarelli, Julio; Barreira, Amilton et al.

Part of Multiple Sclerosis Journal, p. 772-775, 2012

• DOI for Autologous hematopoietic stem cell transplantation for multiple sclerosis: if confused or hesitant, remember 'Treat with standard immune suppressive drugs and if no inflammation, no response'

Bilateral and recurrent optic neuritis in multiple sclerosis

Burman, Joachim; Raininko, Raili; Fagius, Jan

Part of Acta Neurologica Scandinavica, p. 207-210, 2011

• DOI for Bilateral and recurrent optic neuritis in multiple sclerosis

T regulatory cells lacking CD25 are increased in MS during relapse

Fransson, Moa; Burman, Joachim; Lindqvist, Camilla; Atterby, Christina et al.

Part of Autoimmunity, p. 590-597, 2010

• DOI for T regulatory cells lacking CD25 are increased in MS during relapse

Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder: recommendations from ECTRIMS and the EBMT

Muraro, Paolo A.; Mariottini, Alice; Greco, Raffaella; Burman, Joachim et al.

Part of Nature Reviews Neurology, p. 140-158, 2025

• DOI for Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder: recommendations from ECTRIMS and the EBMT

New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis

Burt, Richard K.; Muraro, Paolo A.; Farge, Dominique; Oliveira, Maria Carolina et al.

Part of Bone Marrow Transplantation, p. 1509-1517, 2021

• DOI for New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis

Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

Momtazmanesh, Sara; Shobeiri, Parnian; Saghazadeh, Amene; Teunissen, Charlotte E. et al.

Part of Reviews in the Neurosciences, p. 573-595, 2021

• DOI for Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)

Roberts, Fiona; Hobbs, Helen; Jessop, Helen; Bozzolini, Cristina et al.

Part of Frontiers in Neurology, 2020

• DOI for Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)
• Download full text (pdf) of Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Bridel, Claire; van Wieringen, Wessel N.; Zetterberg, Henrik; Tijms, Betty M. et al.

Part of JAMA Neurology, p. 1035-1048, 2019

• DOI for Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Autologous haematopoietic stem cell transplantation for neurological diseases

Burman, Joachim; Tolf, Andreas; Hägglund, Hans; Askmark, Håkan

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 147-155, 2018

• DOI for Autologous haematopoietic stem cell transplantation for neurological diseases
• Download full text (pdf) of Autologous haematopoietic stem cell transplantation for neurological diseases

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society

Vågberg, M; Axelsson, M; Birgander, R; Burman, Joachim et al.

Part of Acta Neurologica Scandinavica, p. 17-24, 2017

• DOI for Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
• Download full text (pdf) of Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society

Neurologi

Nyholm, Dag; Burman, Joachim

Liber, 2020

Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders

Kirgizov, Kirill; Burman, Joachim; Snowden, John A.; Greco, Raffaella

Part of Handbook of Clinical Neurology, p. 249-258, Elsevier, 2024

• DOI for Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders

Den neurologiska konsultationen

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Part of Neurologi, Liber, 2020

Neurologisk symtomlära

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Part of Neurologi, Liber, 2020

Curing Multiple Sclerosis: How to do it and how to prove it

Burman, Joachim

2014

• Download full text (pdf) of Curing Multiple Sclerosis: How to do it and how to prove it

Engineered T regulatory cells target CNS and suppress active EAE upon intra nasal delivery

Fransson, Moa; Piras, E; Wang, H; Burman, Joachim et al.

Human Mesenchymal stromal cells expressing a CNS-targeting receptor can be administrated intra nasally and cure expersimental autoimmune enchphlomyelitis

Fransson, Moa; Piras, E; Wang, H; Burman, Joachim et al.

A biochemical signature of progressive multiple sclerosis

Herman, Stephanie; Emami Khoonsari, Payam; Bergman, Joakim; Svenningsson, Anders et al.

Biological markers for CNS damage in a patient cohort with suspected autoimmune psychiatric disease

Syk, Mikaela; Malmström, Emma; Gallwitz, Maike; Fällmar, David et al.

Cerebral blood flow in multiple sclerosis: an ¹⁵O-water PET study

Tolf, Andreas; Hedman, Karolina; Appel, Lieuwe; Larsson, Elna-Marie et al.

Identifying transition to secondary progressive multiple sclerosis across international registries using uncertainty-aware machine learning

Parakkal Sreenivasan, Akshai; Noui, Yassine; Erngren, Ida; Spjuth, Ola et al.

Prospective validation of a machine learning model for early identification of secondary progressive multiple sclerosis

Parakkal Sreenivasan, Akshai; Noui, Yassine; Erngren, Ida; Spjuth, Ola et al.